Skip to main content
All Posts By

Megan Gage Witbracht

Healthy, Drug-Resistant Microglia Reinvigorate Mouse Brain

By Carousel Slider, In the News, UCI MIND

UCI MIND faculty member and professor, Mathew Blurton-Jones, PhD, is featured in AlzForum for his lab’s recent collaborative work on creating a new strain of resistant microglia. Lead author and graduate student in the Blurton-Jones lab, Jean Paul Chadarevian, along with collaborators at the University of Pennsylvania published their innovative work in Journal of Experimental Medicine in the December 2022 issue. Read the full article here >

The post Healthy, Drug-Resistant Microglia Reinvigorate Mouse Brain appeared first on UCI MIND.

Read More

UCI MIND Faculty Responds to AlzForum Article: How Will Alzheimer’s Trials, Treatment Change in 2023 and Beyond?

By Carousel Slider, UCI MIND

Responding the the original article written in AlzForum on the future of Alzheimer’s treatment and research from October 7th, Joshua Grill, PhD from UCI MIND, and his colleague, Jason Karlawish, MD, from University of Pennsylvania, write: “Anticipation that FDA will grant full approval of lecanemab (or another disease-modifying treatment) invites an exciting but challenging thought exercise: How will such treatments change research and practice for Alzheimer’s disease (AD)? We’ve considered some of the issues. Our top line point is that a new disease-slowing treatment is unlikely to make use of placebo controls immediately and categorically unethical (Grill and Karlawish, 2021)….

The post UCI MIND Faculty Responds to AlzForum Article: How Will Alzheimer’s Trials, Treatment Change in 2023 and Beyond? appeared first on UCI MIND.

Read More
English